New impact metric

In an attempt to provide alternative metrics to the traditional journal impact factor, the open-access journal __Public Library of Science ONE__ announced that it will release a slew of alternative impact data about individual articles in the coming months. The new "articles-level metrics project" -- which will post usage data, page views, citations from linkurl:Scopus;http://info.scopus.com/ and linkurl:CrossRef,;http://www.crossref.org/ social networlking links, press coverage, comments, and

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
In an attempt to provide alternative metrics to the traditional journal impact factor, the open-access journal __Public Library of Science ONE__ announced that it will release a slew of alternative impact data about individual articles in the coming months. The new "articles-level metrics project" -- which will post usage data, page views, citations from linkurl:Scopus;http://info.scopus.com/ and linkurl:CrossRef,;http://www.crossref.org/ social networlking links, press coverage, comments, and user ratings for each of __PLoS ONE__'s thousands of articles -- was announced yesterday (Jan. 18) by linkurl:Peter Binfield,;=http://www.plos.org/about/people/one.html the journal's managing editor, at the linkurl:ScienceOnline'09;http://www.scienceonline09.com/ conference in Research Triangle Park, North Carolina.
"No one has any data other than [ISI] impact factors," Binfield told __The Scientist__. "Our idea is to throw up a bunch of metrics and see what people use." From its inception at the end of 2006, __PLoS ONE__ has eschewed the notion of impact factors. (It is not currently listed by the ISI Web of Science's rankings.) Binfield argued that the traditional impact factor judges a journal's overall performance, rather than assessing impact at the article-level. The new scheme, however, is aimed at evaluating each article on its own merits, regardless of the other papers in the same journal, he said. __PLoS ONE__ doesn't plan to crunch the data itself, though. "We're not being arrogant enough to make our own metric," said Binfield. Rather, he hopes that the journal's readers will use the information to come to their conclusions. "We're putting the data out there and letting the world figure it out." Eventually, Binfield hopes that readers will be able to personalize how they view the data, and sort articles according to the metric of their choice. "The more metrics we have, the more it'll lead to a dilution of any one [metric]," said linkurl:Bjoern Brembs,;http://bjoern.brembs.net/ a neuroscientist at the Free University of Berlin in Germany and member of __PLoS ONE__'s editorial board.
**__Related stories:__***linkurl:Impact factors and publishing research;http://www.the-scientist.com/article/display/13247/
[16th September 2002]*linkurl:PLoS plans to publish its own journals;http://www.the-scientist.com/article/display/19886/
[7th September 2001]*linkurl:Long-term vs. short-term journal impact: Does it matter?;http://www.the-scientist.com/article/display/17900/
[2nd February 1998] *linkurl:Dispelling a few common myths about journal citation impacts;http://www.the-scientist.com/article/display/17383/
[3rd February 1997]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Elie Dolgin

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide